Bisopair H Tablet: A High-Demand Cardiac Product for Your PCD Pharma Franchise

The Growing and Essential Market for Combination Therapy in Hypertension

Understanding the Synergistic Action of Bisoprolol and Hydrochlorothiazide

Why Bisopair H is the Ideal Choice for Your B2B Pharma Portfolio

Quality, Efficacy, and Our Commitment to Your Success
How to Begin Your Monopoly Franchise with a Cardiac Product

Home/Products /bisoprolol-fumarate-5mg-hydrochlorothiazide-6-25mg-tablet

About the Product

Description


In the critical and consistently high-demand field of cardiovascular care, fixed-dose combination products are highly sought after for their convenience and enhanced efficacy. Bisopair H Tablet, with its powerful combination of Bisoprolol Fumarate (5mg) and Hydrochlorothiazide (6.25mg), is a best-in-class product for the effective management of hypertension (high blood pressure). As a PCD pharma company, we recognize the consistent demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.

Bisoprolol Fumarate, a beta-blocker, works by reducing the workload on the heart and slowing the heart rate, while Hydrochlorothiazide, a thiazide diuretic, helps the body eliminate excess fluid and sodium. The synergistic effect of these two components provides a more potent and comprehensive blood pressure-lowering action than either drug alone, which often leads to better patient outcomes and compliance. This well-established therapeutic combination makes Bisopair H Tablet a trusted choice for doctors and a stable, high-demand product for the market.

At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Bisopair H Tablet is manufactured under strict quality controls and comes with a competitive pricing structure. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the cardiology segment.

Common side effects may include dizziness, headache, flushing, slow heart rate, nausea, or fatigue. Rarely, may cause edema, allergic reactions, or elevated liver enzymes.

Hypertension (to reduce the risk of heart attack and stroke) Chronic stable angina Supraventricular tachycardia and rhythm disorders (as advised by a physician)

Swallow the tablet whole—do not crush or chew. Use only under medical supervision. Monitor blood pressure and heart rate regularly. Caution is advised in patients with liver disease, heart block, or congestive heart failure.

Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Bisoprolol Fumarate 5mg + Hydrochlorothiazide 6.25mg Tablet in the PCD pharma franchise market?

This antihypertensive combination has strong and consistent demand in the cardiology and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on blood pressure management portfolios.

Why should medical distributors include this combination tablet in their product range?

Medical distributors and agencies can benefit from steady long-term demand for management of hypertension (high blood pressure), fluid retention-related BP cases, and cardiovascular risk control. Bisoprolol reduces heart rate and cardiac workload Hydrochlorothiazide is a diuretic that helps remove excess fluid and lowers blood pressure Together, they provide effective dual-action BP control, strengthening a reliable cardiovascular portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong cardiology prescription demand, chronic daily-use therapy, high repeat sales, stable market movement, reliable supply chain support, and good margins in cardiovascular medicines.

How can I become a distributor or franchise partner for this tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, territory rights, and distribution opportunities.